Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cepheid
Age
18–100
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
prospective specimens:
* Patient is at least 18 years of age
* Patient has provided documented informed consent as required by the reviewing IRB. Experimental Bill of Rights will also be documented for all subjects enrolled in applicable states.
* Patient has been diagnosed with CML.
* Patient consents to provide at least 12 mL of peripheral blood for study purposes
frozen specimens:
* Specimen is from a subject diagnosed with CML
* Specimen meets the manufacturer's criteria to support testing by both diagnostic assays
You may not be if
prospective specimens:
* Patient is considered to be of insufficient health to supply the required volume of peripheral blood by his/her health care provider
* Patient has been previously enrolled
frozen specimens: • Specimen previously enrolled
Clareo Health | Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML)
